COMP <GO>
CTRN vs PG // EV/EBITDA & P/E VALUATION
Citi Trends Inc. (NASDAQ) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: CTRN 2
— PG 9
▲ EV/EBITDA & P/E VALUATION LEADER: PG
LAST: $48.16 (-0.78%) • MKT CAP: $404.8M
valuation
105.1x
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
valuation
16.2x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CTRN VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CTRN | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 51.20% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.60% | 25.40% | -22.80 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 105.1x | 16.2x | +88.90 | PG | /valuation <GO> |
| Free Cash Flow Yield | 5.18% | 3.77% | +1.41 | CTRN | /fcf-yield <GO> |
| Operating Margin | 0.50% | 24.30% | -23.80 | PG | /operating-margins <GO> |
| Net Profit Margin | 0.60% | 19.00% | -18.40 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 8.90% | 0.30% | +8.60 | CTRN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.34 | 5.59 | -2.25 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.7 | 60.3 | -14.60 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.87 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 72.4x | 21.7x | +50.70 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $404.8M | $372.21B | -$371.81B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CTRN REV | PG REV | CTRN GROSS % | PG GROSS % | CTRN FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $820.0M | $84.28B | — | 51.2% | $21.0M | $14.04B |
| FY 2024 | $753.1M | $84.04B | — | 51.4% | -$3.8M | $16.52B |
| FY 2023 | $747.9M | $82.01B | — | — | -$9.6M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CTRN // BETA —
PG // BETA 0.87